New Drug Development Platform

An organ-on-chip platform specifically designed for pharmaceutical and biotech drug development and testing. Combines 3D human tissue models with dynamic flow simulation to predict drug efficacy and safety in clinically relevant conditions.

Technology platform for developing and testing microphysiological systems that simulate human organ and tissue behavior in vitro. Enables preclinical drug testing, toxicology assessment, and disease modeling with improved physiological relevance compared to conventional cell cultures. Integrates microfluidics, tissue engineering, and analytical capabilities for pharmaceutical and biomedical research applications.

An organ-on-chip technology platform that combines clinically relevant tissue size with independent millifluidic environments and fully controlled fluid flow. Enables 3D humanized tissue models with dynamic flow environments to mimic physiological conditions for in vitro testing and research.

MIVO® Single-Organ Platform is an organ-on-chip device that combines clinically relevant tissue dimensions with independent millifluidic environments for controlled 3D cell culture and drug testing. The platform enables realistic, reproducible in vitro modeling of human organ physiology and disease states, supporting accelerated drug discovery and personalized therapy development.

Integrated system supporting development and optimization of diagnostic assays from initial design through manufacturing. Enables rapid prototyping and scaling of diagnostic solutions. Facilitates transition from concept to commercial production.

System for large-scale screening applications using microarray and biosensor technologies. Supports multiplexed analysis of thousands of samples or compounds simultaneously. Enables rapid identification of biomarkers and therapeutic targets.

Integrated microfluidic platform for organ-on-chip and cell culture applications with biocompatible material options. Supports long-term cell maintenance with precise fluidic control for physiological simulation.

Molecular testing platform for analyzing drug metabolism genes and variants. Supports personalized medicine and medication selection in clinical practice.

Comprehensive platform for developing and manufacturing medical diagnostic instruments. The platform enables creation of detection devices for clinical laboratory and point-of-care applications.

Data-driven diagnostic platform providing single-cell resolution analysis for unprecedented disease insight and ultra-sensitive diagnostics. Enables discovery of hidden cellular biomarkers in disease states.

System for manufacturing protein microarrays and biosensors for large-scale protein screening. Delivers multiplexed diagnostics and biomarker detection with high sensitivity. Supports comprehensive proteomics research and development.

Proprietary microfluidics technology platform designed for point-of-care testing and molecular diagnostics applications. Enables precise fluid handling and sample processing in miniaturized formats for rapid diagnostic analysis.